{"status":"OK","data":{"id":2681683,"identifier":"DVN/RVIR3E","persistentUrl":"https://doi.org/10.7910/DVN/RVIR3E","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2016-06-15","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/RVIR3E","latestVersion":{"id":70383,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/RVIR3E","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","UNF":"UNF:6:SB+PSE5t4HYqPEAZ6QTosg==","lastUpdateTime":"2016-06-15T23:10:21Z","releaseTime":"2016-06-15T23:10:21Z","createTime":"2015-06-09T11:32:39Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Patients' characteristics of studies reporting induction with rituximab in AAV"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"besada, emilio"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"UiT the Arctic University of Norway"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"besada, emilio"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"UiT the Arctic University of Norway"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"emilio.besada@uit.no"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"Patients' characteristics of studies reporting induction with rituximab in AAV. Studies have 9 patients or more to be included. Collected vis PubMed January 2015."},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2015-06-09"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"induction"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"rituximab"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"anca-associated vasculitis"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"granulomatosis with polyangiitis"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"patients' characteristics"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"besada, emilio"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2015-06-09"}]}},"files":[{"description":"patients' characteristics in induction studies with rituximab in AAV","label":"gpaindu.tab","restricted":false,"version":2,"datasetVersionId":70383,"dataFile":{"id":2681684,"persistentId":"doi:10.7910/DVN/RVIR3E/6W6G1S","pidURL":"https://doi.org/10.7910/DVN/RVIR3E/6W6G1S","filename":"gpaindu.tab","contentType":"text/tab-separated-values","filesize":3074,"description":"patients' characteristics in induction studies with rituximab in AAV","storageIdentifier":"s3://dvn-cloud:14dd816a782-2b26f289f02b","originalFileFormat":"application/x-spss-sav","originalFormatLabel":"SPSS SAV","UNF":"UNF:6:SB+PSE5t4HYqPEAZ6QTosg==","rootDataFileId":-1,"md5":"a6675d996600a016f2056b9283c9dc61","checksum":{"type":"MD5","value":"a6675d996600a016f2056b9283c9dc61"}}}]}}}